APA (7th ed.) Citation

Pechacek, J., Schmitt, M. M., Ferrè, E. M. N., Webb, T., Goldberg, J., Pathan, S., . . . Lionakis, M. S. (2024). Successful Treatment of Refractory Cutaneous Protothecosis With MAT2203, an Oral Lipid Nanocrystal Formulation of Amphotericin B. Open Forum Infectious Diseases, 11(8), 1. https://doi.org/10.1093/ofid/ofae428

Chicago Style (17th ed.) Citation

Pechacek, Joseph, et al. "Successful Treatment of Refractory Cutaneous Protothecosis With MAT2203, an Oral Lipid Nanocrystal Formulation of Amphotericin B." Open Forum Infectious Diseases 11, no. 8 (2024): 1. https://doi.org/10.1093/ofid/ofae428.

MLA (9th ed.) Citation

Pechacek, Joseph, et al. "Successful Treatment of Refractory Cutaneous Protothecosis With MAT2203, an Oral Lipid Nanocrystal Formulation of Amphotericin B." Open Forum Infectious Diseases, vol. 11, no. 8, 2024, p. 1, https://doi.org/10.1093/ofid/ofae428.